Description
Semaxa contains oral Semaglutide, a GLP‑1 receptor agonists used for the management of Type 2 Diabetes.
It helps improve glycemic control by stimulating glucose-dependent insulin secretion, reducing glucagon release, and slowing gastric emptying.
Taken once daily, Semaxa also supports weight reduction in adults with type 2 diabetes.
